Table 5.
Effect of in utero choline exposure on Angus × Holstein calf feed blood metabolites while on a finishing diet at approximately 8 to 9 mo of age presented as least square means and 95% CI
| Treatment1 | Sex | P-value | Contrasts2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Item | CTL | RPC1RD | RPC2RD | RPC2HD | Male | Female | Trt | Sex | Trt × Sex | A | B |
| Glucose, mg/dL | 95.6 | 85.0 | 92.4 | 89.9 | 91.5 | 89.9 | 0.48 | 0.82 | 0.24 | <0.01 | 0.02 |
| [91.3, 99.9] | [79.4, 90.7] | [88.0, 96.9] | [86.0, 94.0] | [87.7, 95.4] | [87.3, 92.5] | ||||||
| Insulin, µg/L | 4.4a | 1.4b | 3.1a,b | 1.9b | 2.3 | 3.0 | 0.01 | 0.24 | 0.28 | <0.01 | 0.001 |
| [3.1, 6.0] | [0.5, 2.7] | [1.9, 4.5] | [1.3, 2.8] | [1.4, 3.3] | [2.3, 3.7] | ||||||
| BUN, mg/dL | 5.4 | 5.6 | 5.5 | 5.4 | 5.2 | 5.7 | 0.93 | 0.04 | 0.19 | 0.91 | 0.94 |
| [5.0, 5.9] | [5.0, 6.2] | [5.1, 6.0] | [5.0, 5.8] | [4.9, 5.6] | [5.5, 6.0] | ||||||
| Fatty acids, mM | 0.10 | 0.12 | 0.09 | 0.09 | 0.10 | 0.10 | 0.31 | 0.87 | 0.21 | 0.63 | 0.46 |
| [0.08, 0.12] | [0.09, 0.15] | [0.07, 0.11] | [0.07, 0.11] | [0.08, 0.12] | [0.09, 0.11] | ||||||
| Triglyceride, mg/dL | 18.1 | 14.6 | 16.0 | 16.0 | 16.2 | 16.1 | 0.49 | 0.95 | 0.27 | 0.09 | 0.20 |
| [15.2, 21.6] | [11.4, 18.6] | [13.3, 19.2] | [13.5, 18.9] | [13.8, 18.9] | [14.3, 18.0] | ||||||
| BHB, mM | 0.28a | 0.24a | 0.31a,b | 0.37b | 0.31 | 0.29 | 0.01 | 0.61 | 0.16 | 0.29 | 0.02 |
| [0.23, 0.32] | [0.18, 0.31] | [0.27, 0.36] | [0.33, 0.41] | [0.27, 0.35] | [0.27, 0.32] | ||||||
| RQUICKI | 0.34a | 0.41a | 0.38a | 0.42b | 0.40 | 0.38 | 0.001 | 0.28 | 0.46 | <0.001 | <0.001 |
| [0.36, 0.33] | [0.47, 0.36] | [0.42, 0.35] | [0.47, 0.39] | [0.43, 0.37] | [0.40, 0.36] | ||||||
| Glucose:Insulin | 21.6a | 59.9b | 29.6a,b | 45.5b | 40.5 | 30.5 | 0.01 | 0.22 | 0.29 | <0.01 | <0.01 |
| [16.0, 30.8] | [32.4, 146.0] | [20.7, 46.0] | [30.5, 75.1] | [28.1, 63.4] | [24.3, 39.4] | ||||||
1CTL = 0 g/d supplemental RPC; RPC1RD = 15 g/d supplemental RPC (ReaShure; Balchem Corp.); RPC2RD = 15 g/d supplemental RPC in concentrated prototype (Balchem Corp.); RPC2HD = 22 g/d supplemental RPC in concentrated prototype (Balchem Corp.).
2Contrast A: CTL vs. RPC; Contrast B: linear dose of RPC.
a,b,cMeans within a row with different letters differ (P < 0.05).